Search Results - "BERREUR, M"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Adhesion and osteogenic differentiation of human mesenchymal stem cells on titanium nanopores by Lavenus, Sandrine, Berreur, Martine, Trichet, Valerie, Pilet, Paul, Louarn, Guy, Layrolle, Pierre

    Published in European cells & materials (26-08-2011)
    “…Titanium implants are widely used in orthopaedic and dental surgery. Surface properties play a major role in cell and tissue interactions. The adhesion and…”
    Get full text
    Journal Article
  2. 2

    Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients by Chemel, M, Le Goff, B, Brion, R, Cozic, C, Berreur, M, Amiaud, J, Bougras, G, Touchais, S, Blanchard, F, Heymann, M F, Berthelot, J M, Verrecchia, F, Heymann, D

    Published in Annals of the rheumatic diseases (01-01-2012)
    “…Interleukin (IL) 34 is a new cytokine implicated in macrophage differentiation and osteoclastogenesis. This study assessed IL-34 expression in the tissue of…”
    Get more information
    Journal Article
  3. 3

    Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model by Córdova, L.A., Trichet, V., Escriou, V., Rosset, P., Amiaud, J., Battaglia, S., Charrier, C., Berreur, M., Brion, R., Gouin, F., Layrolle, P., Passuti, N., Heymann, D.

    Published in Acta biomaterialia (01-02-2015)
    “…[Display omitted] Receptor activator of nuclear factor kappa-B (RANK) and RANK-ligand are relevant targets for the treatment of polyethylene particle-induced…”
    Get full text
    Journal Article
  4. 4

    Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B by Mori, K, Le Goff, B, Berreur, M, Riet, A, Moreau, A, Blanchard, F, Chevalier, C, Guisle-Marsollier, I, Léger, J, Guicheux, J, Masson, M, Gouin, F, Rédini, F, Heymann, D

    Published in The Journal of pathology (01-04-2007)
    “…RANK, RANK ligand (RANKL) and osteoprotegerin (OPG) are the key regulators of bone metabolism, both in normal and pathological conditions. Previous data have…”
    Get full text
    Journal Article
  5. 5

    Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53 by CHIPOY, C, BROUNAIS, B, TRICHET, V, BATTAGLIA, S, BERREUR, M, OLIVER, L, JUIN, P, REDINI, F, HEYMANN, D, BLANCHARD, F

    Published in Oncogene (11-10-2007)
    “…Oncostatin M (OSM), a cytokine of the interleukin-6 family, induces growth arrest and differentiation of osteoblastic cells into glial-like/osteocytic cells…”
    Get full text
    Journal Article
  6. 6

    Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats by Perrin, P, Pierre, F, Patry, Y, Champ, M, Berreur, M, Pradal, G, Bornet, F, Meflah, K, Menanteau, J

    Published in Gut (01-01-2001)
    “…BACKGROUND Dietary fibres have been proposed as protective agents against colon cancer but results of both epidemiological and experimental studies are…”
    Get full text
    Journal Article
  7. 7

    Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells by Ory, B., Moriceau, G., Trichet, V., Blanchard, F., Berreur, M., Rédini, F., Rogers, M., Heymann, D.

    Published in Journal of cellular and molecular medicine (01-06-2008)
    “…We recently demonstrated original anti‐tumor effects of zoledronic acid (Zol) on osteosarcoma cell lines independently of their p53 and Rb status. The present…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor κB ligand and MAPK by Theoleyre, S, Wittrant, Y, Couillaud, S, Vusio, P, Berreur, M, Dunstan, C, Blanchard, F, Rédini, F, Heymann, D

    “…Osteoprotegerin (OPG) is a decoy receptor for receptor activator of nuclear factor κB ligand (RANKL), an inducer of osteoclastogenesis via its receptor RANK…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Receptor activator of nuclear factor-κB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells by Mori, Kanji, Berreur, Martine, Blanchard, Fréderic, Chevalier, Catherine, Guisle-Marsollier, Isabelle, Masson, Martial, Rédini, Françoise, Heymann, Dominique

    Published in Oncology reports (01-12-2007)
    “…Receptor activator of nuclear factor Kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) are the key regulators of bone metabolism. Recent findings…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells by Brounais, Bénédicte, David, Emmanuelle, Chipoy, Céline, Trichet, Valérie, Ferré, Virginie, Charrier, Céline, Duplomb, Laurence, Berreur, Martine, Rédini, Françoise, Heymann, Dominique, Blanchard, Frédéric

    Published in Bone (New York, N.Y.) (01-05-2009)
    “…Abstract Previous in vitro studies on primary osteoblastic and osteosarcoma cells (normal and transformed osteoblasts) have shown that oncostatin M (OSM), a…”
    Get full text
    Journal Article
  14. 14

    Effects of interferon gamma (IFN gamma) and tumor necrosis factor alpha (TNF alpha) association in intraperitoneal radioimmunotherapy: studies on an in vitro micrometastasis model by Imbert-Marcille, B M, Berreur, M, Thedrez, P, Riet, A, Devys, A, Chatal, J F, Pradal, G

    Published in Anti-cancer drug design (01-09-1995)
    “…We considered the usefulness of an association of two cytokines interferon gamma (INF gamma) and tumor necrosis factor alpha (TNF alpha) in optimizing…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Electron microscopy study of intrahepatic ultrasmall superparamagnetic iron oxide kinetics in the rat. Relation with magnetic resonance imaging by Dupas, Benoit, Berreur, Martine, Rohanizadeh, Ramin, Bonnemain, Bruno, Meflah, Khaled, Pradal, Gilbert

    Published in Biology of the cell (01-06-1999)
    “…Ultrasmall superparamagnetic iron oxide (USPIO) contrast agents for use in magnetic resonance imaging (MRI) are currently undergoing clinical evaluation…”
    Get full text
    Journal Article
  17. 17

    Differentiation of mucous neck cells into parietal cells: a new concept of mitochondrial biogenesis by Pradal, Gilbert, Berreur, Martine, Pouyet, Brigitte, Riet, Anne

    Published in Biology of the cell (01-10-2000)
    “…Parietal cells of the gastric fundic mucosa are small and contain only a few tiny mitochondria when they begin to differentiate from mucous neck cells. The…”
    Get full text
    Journal Article
  18. 18

    Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK by Theoleyre, S, Wittrant, Y, Couillaud, S, Vusio, P, Berreur, M, Dunstan, C, Blanchard, F, Rédini, F, Heymann, D

    Published in Biochimica et biophysica acta (02-02-2004)
    “…Osteoprotegerin (OPG) is a decoy receptor for receptor activator of nuclear factor kappaB ligand (RANKL), an inducer of osteoclastogenesis via its receptor…”
    Get more information
    Journal Article
  19. 19

    Ultrastructural study of degradation of calcium phosphate ceramic by human monocytes and modulation of this activity by HILDA/LIF cytokine by Benahmed, MD, Heymann, D, Berreur, M, Cottrel, M, Godard, A, Daculsi, G, Pradal, G

    “…Biodegradation of ceramics in vivo is achieved essentially by monocytes and multinuclear cells (osteoclasts). Monocytes are the key element in this process…”
    Get full text
    Journal Article